| Modification | Date |
| Change to section 4.8 - Undesirable Effects | 23/10/2009 10:25:00 |
| Improved Electronic Presentation | 23/10/2009 10:25:00 |
| Change to section 7 - Marketing Authorisation Holder | 15/01/2008 15:19:27 |
| Change to section 7 - Marketing Authorisation Holder | 19/12/2007 12:15:43 |
| Change to section 5.1 - Pharmacodynamic Properties | 19/12/2007 12:15:43 |
| Change to section 4.4 - Special warnings and precautions for Use | 19/12/2007 12:15:43 |
| Change to section 6.2 - Incompatibilities | 23/10/2007 12:09:21 |
| Change to section 5.1 - Pharmacodynamic Properties | 23/10/2007 12:09:21 |
| Change to section 4.4 - Special warnings and precautions for Use | 23/10/2007 12:09:21 |
| Change to section 7 - Marketing Authorisation Holder | 04/09/2007 17:04:16 |
| Change to section 5.1 - Pharmacodynamic Properties | 04/09/2007 17:04:16 |
| Change to section 4.4 - Special warnings and precautions for Use | 04/09/2007 17:04:16 |
| Change to section 10 (date of (partial) revision of the text | 10/08/2007 13:33:11 |
| Change to section 7 - Marketing Authorisation Holder | 10/08/2007 13:33:11 |
| Change to section 10 (date of (partial) revision of the text | 11/12/2001 15:46:44 |
| Change to section 7 - Marketing Authorisation Holder | 11/12/2001 15:46:44 |
|